1Kannel WB.Fifty years of Framingham study contributions to understanding hypertension[J].J Hum Hypertens,2000,14(2):83-90.
2Thomas F,Bean K,Guize L,et al.Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young(《55 years)men and women[J].Eur Heart J,2002,23(7):528-535.
10Gregorio-King CC,Gough T,Van Der Meer GJ,et al.Mechanisms of resistance to the cytotoxic effects of oxysterols in human leukemic cells[J].Steroid Biochem Mol Biol,2004,88(3):311-320.
5Williams RR,Hunt SC,Hopkins PN,et al.Familial dyslipidemic hypertension:Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension[J].JAMA,1988,259(24):3579-3586.
6Julius S,Jamerson K,Mejia A,et al.The association of borderline hypertension with target organ changes and higher coronary risk:Tecumseh blood pressure study[J].JAMA,1990,264:354-358.
7Bonaa KH, Thelle DS.Association between blood pressure and serum lipids in a population the Tromso study [ J ]. Circulation,1991,83:1305 - 1314.
8Hjermann I, Helgeland A, Holme I, et al. The association between blood pressure and serum cholesterol in healthy men: the Oslo study[J]. J Epidemiol Community Health, 1978,32(2) : 117 - 23.
9Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study[J]. Am J Med, 1986 Feb 14,80(2A) :23 - 32.
10Crlqui MH, Cowan LID, Heiss G. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study[J ]. Circulation, 1986, 73( 1 Pt 2):I40-50.
